EndoCross

Medical Devices for Cardiovascular Treatment

Health Tech & Life Sciences
Non Active, Oct 2017
Mature Yokne'am Illit, Israel Founded 2006
LinkedIn
Last updated 2026-06-18
Total raised
$2.5M
Last: 2008-11
Stage
Mature
Founded
2006
Headcount
500+
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

EndoCross develops and markets solutions to treat challenging lesions, including chronic total occlusions (CTOs). Its first product, the ENABLER-P Catheter System, is CE marked and designed for use in the peripheral vasculature, including above-the-knee and below-the-knee vessels. The company is also introducing the ENABLER-C Catheter System for use in coronary environments. The ENABLER technology can advance a guidewire in challenging environments, including crossing long and severely calcified CTOs. Using traditional balloon technologies, EndoCross has developed a balloon designed to provide guidewire support, centralization, and controlled advancement. The full ENABLER Catheter System comprises the ENABLER-P Catheter, the ENABLER Pressure Control Unit, a syringe set, and a sterile cover.

Funding history · 1 round · $2.5M total

2008-11

Q&A

What is EndoCross's primary focus?
EndoCross develops and markets medical devices for cardiovascular treatment, specifically solutions to treat challenging lesions, including chronic total occlusions (CTOs).
What is the status of EndoCross?
EndoCross is currently inactive, a status it reached in October 2017.
What is EndoCross's flagship product?
EndoCross's first product is the ENABLER-P Catheter System, which is CE marked and designed for use in the peripheral vasculature. The company is also introducing the ENABLER-C Catheter System for use in coronary environments.
When was EndoCross founded?
EndoCross was founded in January 2006.
How much funding has EndoCross raised in total?
EndoCross has raised a total of $2,500,000.
Which investors participated in EndoCross's funding round?
In November 2008, EndoCross raised $2,500,000 from investors including Viola Growth.
Who is a key founder of EndoCross?
Eran Hirszowicz is a founder and serves as the Chief Technology Officer of EndoCross.

Team · 1

Founder · Chief Technology Officer & Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cathetersmedical-deviceshospitalscardiovascularsurgeryvascularcardiology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)